Medicare Enrolled
Dr. Vinod Miryala, MD
Cardiovascular Disease · The Villages, FL
Practice pattern: Remote Monitoring— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miryala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miryala? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miryala
Dr. Vinod Miryala is a cardiovascular disease in The Villages, FL, with 18 years in practice. Based on federal Medicare data, Dr. Miryala performed 12,337 Medicare services across 5,686 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miryala received a total of $7,334 from 47 pharmaceutical and/or device companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miryala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 5% volume in FL$ $7,334 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,337
Medicare services
Top 5% in FL for cardiovascular disease
5,686
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~685 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring device, 30 days | 1,960 | $35 | $95 |
| Remote patient monitoring management, 20 min/month | 1,824 | $34 | $96 |
| Office visit, established patient (30-39 min) | 1,087 | $91 | $254 |
| Regadenoson injection (Lexiscan) for heart stress test | 651 | $41 | $234 |
| Electrocardiogram (EKG), 12-lead | 527 | $10 | $29 |
| Anticoagulant management of patient taking warfarin | 454 | $8 | $23 |
| Prothrombin time test (blood clotting) | 432 | $4 | $9 |
| Remote pacemaker/defibrillator monitoring, 90 days | 429 | $16 | $43 |
| Office visit, established patient (20-29 min) | 409 | $65 | $179 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 340 | $26 | $140 |
| Echocardiogram, transthoracic | 335 | $110 | $295 |
| Remote pacemaker monitoring, 90 days | 302 | $22 | $60 |
| Hospital follow-up visit, moderate complexity | 233 | $63 | $160 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 203 | $19 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 201 | $51 | $138 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 194 | $313 | $447 |
| Office visit, established patient (10-19 min) | 180 | $41 | $112 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 172 | $85 | $333 |
| Blood draw (venipuncture) | 165 | $8 | $16 |
| Ultrasound of both sides of head and neck blood flow | 164 | $95 | $254 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 143 | $19 | $52 |
| Hospital follow-up visit, high complexity | 142 | $94 | $240 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 128 | $26 | $73 |
| Initial hospital admission, high complexity | 111 | $136 | $350 |
| Office visit, established patient, complex (40-54 min) | 106 | $131 | $357 |
| Nuclear medicine study of heart muscle blood flow by pet | 99 | $139 | $434 |
| Initial hospital admission, moderate complexity | 92 | $103 | $263 |
| Comprehensive metabolic blood panel | 90 | $10 | $21 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 86 | $325 | $847 |
| Complete blood count (CBC) with differential | 78 | $8 | $16 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 76 | $2,090 | $5,334 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 75 | $31 | $78 |
| Lipid panel (cholesterol and triglycerides) | 64 | $13 | $27 |
| New patient office visit (45-59 min) | 52 | $119 | $334 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 51 | $627 | $1,597 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 50 | $20 | $51 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 47 | $14 | $37 |
| Cardiac catheterization | 40 | $232 | $603 |
| Free thyroxine (T4) test | 39 | $9 | $18 |
| Thyroid stimulating hormone (TSH) test | 39 | $16 | $34 |
| Programming of dual lead pacemaker system | 35 | $57 | $156 |
| Thyroid hormone, t3 measurement, free | 33 | $17 | $34 |
| Ultrasound of leg arteries or artery grafts | 33 | $163 | $465 |
| Ultrasound of heart, follow-up | 31 | $70 | $191 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $10 | $28 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $140 | $366 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 24 | $1,144 | $4,863 |
| Basic metabolic blood panel | 24 | $8 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $16 | $42 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $11 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 21 | $44 | $141 |
| Magnesium level test | 19 | $7 | $14 |
| Natriuretic peptide (heart and blood vessel protein) level | 19 | $38 | $79 |
| Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | 16 | $13 | $26 |
| Lipoprotein (a) level | 15 | $14 | $29 |
| New patient office visit, complex (60-74 min) | 15 | $173 | $440 |
| Troponin (protein) analysis, quantitative | 14 | $12 | $25 |
| New patient office visit (30-44 min) | 14 | $80 | $225 |
| Vitamin B-12 level test | 12 | $15 | $30 |
| Ferritin level test (iron stores) | 11 | $13 | $27 |
| Folic acid level test | 11 | $14 | $30 |
| Iron level test | 11 | $6 | $13 |
| Iron binding capacity test | 11 | $9 | $18 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.3% high complexity
11.6% medium
78.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,334
Total received (2018-2024)
Avg $1,048/year across 7 years
Top 30% in FL for cardiovascular disease
47
Companies
405
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,295 (99.5%)
Other
Charitable contributions, space rental, and other categories
$38 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,508
2023$815
2022$902
2021$636
2020$868
2019$1,436
2018$1,168
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$606
SANOFI-AVENTIS U.S. LLC
$597
PFIZER INC.
$556
Amgen Inc.
$529
Janssen Pharmaceuticals, Inc
$428
Boehringer Ingelheim Pharmaceuticals, Inc.
$413
Boston Scientific Corporation
$369
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$366
AstraZeneca Pharmaceuticals LP
$362
Amarin Pharma Inc.
$315
E.R. Squibb & Sons, L.L.C.
$304
Lundbeck LLC
$198
Abbott Laboratories
$192
Medtronic Vascular, Inc.
$179
ABIOMED
$171
BIOTRONIK INC.
$162
Esperion Therapeutics, Inc.
$155
Impulse Dynamics (USA) Inc.
$150
Merck Sharp & Dohme LLC
$113
Kestra Medical Technology Services, Inc.
$112
Lexicon Pharmaceuticals, Inc.
$94
Regeneron Healthcare Solutions, Inc.
$94
Edwards Lifesciences Corporation
$84
Medtronic, Inc.
$78
Astellas Pharma US Inc
$68
Gilead Sciences, Inc.
$65
Kowa Pharmaceuticals America, Inc.
$63
Alnylam Pharmaceuticals Inc.
$58
Merck Sharp & Dohme Corporation
$47
Chiesi USA, Inc.
$42
Welch Allyn
$38
Philips North America LLC
$36
Novo Nordisk Inc
$32
Biosense Webster, Inc.
$29
Daiichi Sankyo Inc.
$26
Coala Life Inc
$26
Bardy Diagnostics, Inc.
$25
Allergan Inc.
$24
CVRx, Inc.
$21
G Medical Diagnostic Services, Inc.
$18
SCPHARMACEUTICALS INC.
$17
Baxter Healthcare
$15
ARBOR PHARMACEUTICALS, INC.
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Acerta Pharma LLC
$14
Arbor Pharmaceuticals, Inc.
$11
HeartFlow, Inc.
$3
Top 3 companies account for 24.0% of total payments
Associated products mentioned in payments ›
(CK4) MCOT · 3F · AMPLATZER Occluders · AZURE XT DR MRI SURESCAN · Assure WCD · BRILINTA · Barostim Neo System · CAMZYOS · CARTO 3 · CLEVIPREX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Carto 3 System · Coala Heart Monitor · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FUROSCIX · General - Brady · Hillrom - Carnation Ambulatory Monitor · IN.PACT Admiral · INGEVITY · INJECTAFER · Impella · Inpefa · JARDIANCE · KENGREAL · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · Mitra Clip system · MitraClip System · MyCareLink · NEXLETOL · NEXLIZET · NORTHERA · No Associated Product · None · ONPATTRO · OPTIMIZER · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Resolute · Reveal LINQ · SQ-RX PULSE GENERATOR · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VRAYLAR · VYNDAQEL · Varithena Administration Pack · Vascepa · Verquvo · WATCHMAN · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $59 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
76
Per 100K population
55.3
County median income
$73,297
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Miryala is a remote monitoring specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Miryala experienced with remote patient monitoring device, 30 days?
Based on Medicare claims data, Dr. Miryala performed 1,960 remote patient monitoring device, 30 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miryala receive payments from pharmaceutical companies?
Yes. Dr. Miryala received a total of $7,334 from 47 companies across 405 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miryala's costs compare to other cardiovascular diseases in The Villages?
Dr. Miryala's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miryala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in The Villages
Browse cardiovascular diseases in The Villages ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology